样式: 排序: IF: - GO 导出 标记为已读
-
Blood glucose control and metabolic dysfunction-associated steatotic liver disease in people with type 1 diabetes J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-03-18 G. Della Pepa, R. Lupoli, M. Masulli, R. Boccia, R. De Angelis, S. Gianfrancesco, R. Piccolo, C. Rainone, A. A. Rivellese, G. Annuzzi, L. Bozzetto
Purpose Metabolic dysfunction-associated steatotic liver disease (MASLD) may have distinctive pathophysiological features in type 1 diabetes (T1D). We evaluated the independent role of blood glucose control on MASLD in T1D. Methods In a cross-sectional study on 659 T1D adult patients, MASLD was assessed by the Fatty Liver Index (FLI) and the Hepatic Steatosis Index (HSI). Anthropometric, biochemical
-
Overt hypothyroidism in pregnancy and language development in offspring: is there an association? J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-03-18
Abstract Purpose Overt hypothyroidism during pregnancy is linked to various obstetric complications, such as premature birth and fetal death. While some studies have shown that maternal hypothyroidism can impact a child's Intelligence Quotient (IQ) and language development, findings are controversial. The aim of this study was to explore the connection between treated maternal hypothyroidism during
-
Metabolomic profiles of ovariectomized mice and their associations with body composition and frailty-related parameters in postmenopausal women J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-03-17 S. J. Kim, Y. Jo, S. J. Park, E. Ji, J. Y. Lee, E. Choi, J.-Y. Baek, I. Y. Jang, H.-W. Jung, K. Kim, D. Ryu, H. J. Yoo, B.-J. Kim
-
Analysis of the finasteride treatment and its withdrawal in the rat hypothalamus and hippocampus at whole-transcriptome level J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-03-17
Abstract Purpose As reported in patients treated for androgenetic alopecia with finasteride (i.e., a blocker of the enzyme 5 alpha-reductase) and in an animal model, side effects affecting sexual, psychiatric, neurological, and physical domains, may occur during the treatment and persist with drug suspension. The etiopathogenesis of these side effects has been poorly explored. Therefore, we performed
-
Diagnosis and treatment of Paget’s disease of bone: position paper from the Italian Society of Osteoporosis, Mineral Metabolism and Skeletal Diseases (SIOMMMS) J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-03-15 D. Rendina, A. Falchetti, D. Diacinti, F. Bertoldo, D. Merlotti, S. Giannini, L. Cianferotti, G. Girasole, M. Di Monaco, S. Gonnelli, N. Malavolta, S. Minisola, F. Vescini, M. Rossini, B. Frediani, I. Chiodini, F. Asciutti, L. Gennari
-
Temporal trends in the clinical presentation of Graves’ orbitopathy: a single–center retrospective study J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-03-15 R. Le Moli, A. Naselli, F. Lo Giudice, G. Costanzo, F. Frasca, A. Belfiore
-
Psychological symptoms and brain activity alterations in women with PCOS and their relation to the reduced quality of life: a narrative review J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-03-15 J. Pinto, N. Cera, D. Pignatelli
-
CircNRCAM up-regulates NRCAM to promote papillary thyroid carcinoma progression J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-03-14 C. Wang, Z. Wang, L. Fu, J. Du, F. Ji, X. Qiu
-
Hsa_circ_0008360 promotes high glucose-induced damage in HK-2 cells via miR-346/WNT2B axis J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-03-12 L. Zhang, X. Wang
-
Once upon a time: the glucagon stimulation test in diagnosing adult GH deficiency J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-03-10 D. Cuboni, M. Caputo, E. Ghigo, G. Aimaretti, V. Gasco
-
Adipokine secretion and lipolysis following gender-affirming treatment in transgender individuals J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-03-09 N. Subramanian, A. Wiik, E. Rullman, M. Melin, T. R. Lundberg, J. Flanagan, M. Holmberg, A. Dekanski, C. Dhejne, S. Arver, T. Gustafsson, J. Laurencikiene, D. P. Andersson
-
Enhancing gestational diabetes mellitus risk assessment and treatment through GDMPredictor: a machine learning approach J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-03-09 J. Xing, K. Dong, X. Liu, J. Ma, E. Yuan, L. Zhang, Y. Fang
-
Vitamin D and risk of developing type 2 diabetes in the SUN project: a prospective cohort study J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-03-08 A. Valer-Martinez, C. Sayon-Orea, J. A. Martinez, F. J. Basterra-Gortari, M. A. Martinez-Gonzalez, M. Bes-Rastrollo
-
Thyroiditis and COVID-19: focus on pediatric age. A narrative review J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-03-08 F. d’Aniello, M. E. Amodeo, A. Grossi, G. Ubertini
-
Peritoneal metastases in patients with neuroendocrine neoplasms: a challenging site of metastases with clinical and prognostic implications J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-03-07 M. Tsoli, H. Wilson, P. Armonis, L. Kamieniarz, J. Thuringer, R. Mirnezami, M. Caplin, G. Kaltsas, C. Toumpanakis
-
Temporal trends in the starting of insulin therapy in type 2 diabetes in Italy: data from the AMD Annals initiative J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-03-05 A. Giandalia, A. Nicolucci, M. Modugno, G. Lucisano, M. C. Rossi, V. Manicardi, A. Rocca, G. Di Cianni, P. Di Bartolo, R. Candido, D. Cucinotta, G. T. Russo
-
Quality of care and clinical inertia in the management of cardiovascular risk factors in patients with type 1 and type 2 diabetes: data from AMD annals J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-03-04 A. Da Porto, R. Candido, A. Rocca, V. Manicardi, A. Nicolucci, C. Miranda, E. Cimino, P. Di Bartolo, G. Di Cianni, G. Russo
Background Cardiovascular disease is the leading cause of morbidity and mortality among patients with diabetes, and for this reason, all guidelines for CV risk management provide the same targets in controlling traditional CV risk factors in patients with type 1 or type 2 diabetes at equal CV risk class. Aim of our study was to evaluate and compare CV risk management in patients with type 1 and type
-
Serum biomarkers related to frailty predict negative outcomes in older adults with hip fracture J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-03-01 B. Cedeno-Veloz, L. Lozano-Vicario, A. Rodríguez-García, F. Zambom-Ferraresi, A. Galbete, J. Fernández-Irigoyen, E. Santamaría, A. García-Hermoso, R. Calvani, R. Ramírez-Vélez, M. Izquierdo, N. Martínez-Velilla
-
Saint Augustine in his studio by Sandro Botticelli (1445–1510): a representation of Hemochromatosis? J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-02-28 D. de Campos
-
ACROMORFO study: gait analysis in a cohort of acromegalic patients J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-02-28 V. Cimolin, C. Premoli, G. Bernardelli, E. Amenta, M. Galli, L. Donno, D. Lucini, L. M. Fatti, B. Cangiano, L. Persani, G. Vitale
Purpose In acromegaly, skeletal complications resulted to be associated with low quality of life (QoL) and high risk of falls. The aim of the present study was to perform a quantitative assessment of movement through gait analysis technique in patients with acromegaly. Study population Thirty-three acromegalic patients [9 with active disease (AD), 14 with controlled disease (CD) and 10 with disease
-
HMGN1 down-regulation in the diabetic kidney attenuates tubular cells injury and protects against renal inflammation via suppressing MCP-1 and KIM-1 expression through TLR4 J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-02-27 J. Yu, J. Da, F. Yu, J. Yuan, Y. Zha
-
An Italian real-world multicenter study of patients with advanced mixed neuroendocrine non-neuroendocrine neoplasms (MiNENs) of the gastro-entero-pancreatic system treated with chemotherapy J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-02-24 Francesca Spada, Massimo Milione, Patrick Maisonneuve, Natalie Prinzi, Valeria Smiroldo, Elena Bolzacchini, Sara Pusceddu, Carlo Carnaghi, Fausto Sessa, Stefano La Rosa, Silvia Uccella, Nicola Fazio
-
Targeting glutamine metabolism exhibits anti-tumor effects in thyroid cancer J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-02-22 G.-Q. Zhang, C. Xi, N.-T. Ju, C.-T. Shen, Z.-L. Qiu, H.-J. Song, Q.-Y. Luo
-
Novel reference range values for serum testosterone: a cross-sectional study of 200,000 males J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-02-22 Richard J. Fantus, Daniel R. Greenberg, Cecilia Chang, Brian T. Helfand, Jianfeng Xu, Jun Wei, Jonathan E. Shoag, Ajay K. Nangia, Robert E. Brannigan, Joshua A. Halpern
-
Predicting postoperative hypocortisolism in patients with non-aldosterone-producing adrenocortical adenoma: a retrospective single-centre study J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-02-22
Abstract Background Limited information exists on postoperative hypocortisolism and hypothalamus–pituitary–adrenal axis recovery in patients with adrenal incidentaloma following unilateral adrenalectomy. We evaluated frequency of postoperative hypocortisolism and predictors for recovery in non-aldosterone-producing adrenocortical adenoma patients after unilateral adrenalectomy. Methods A retrospective
-
Communication of the diagnosis to Klinefelter subjects: an observational study on a key moment of the patient’s life J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-02-20
Abstract Purpose Klinefelter syndrome (KS) is the most prevalent sex chromosome disorder among males. The communication of the KS diagnosis holds significant implications for the diagnosis's acceptance. Recently, the increased use of prenatal diagnostic procedures has raised the question of whether, when, and by whom information, once provided to parents, should be communicated to their children/adolescents
-
Transition from pediatric to adult care in patients with Turner syndrome in Italy: a consensus statement by the TRAMITI project J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-02-20
Abstract Purpose Transition from pediatric to adult care is associated with significant challenges in patients with Turner syndrome (TS). The objective of the TRansition Age Management In Turner syndrome in Italy (TRAMITI) project was to improve the care provided to patients with TS by harnessing the knowledge and expertise of various Italian centers through a Delphi-like consensus process. Methods
-
Estimate and needs of the transgender adult population: the SPoT study J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-02-19 A. D. Fisher, M. Marconi, G. Castellini, J. D. Safer, S. D’Arienzo, M. Levi, L. Brogonzoli, R. Iardino, C. Cocchetti, A. Romani, F. Mazzoli, P. Matarrese, V. Ricca, L. Vignozzi, M. Maggi, M. Pierdominici, J. Ristori
-
Effectiveness of oral semaglutide on glucose control and body weight up to 18 months: a multicenter retrospective real-world study J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-02-18
Abstract Aim Oral semaglutide, an innovative orally administered GLP-1 receptor agonist for type 2 diabetes (T2D) management was herein evaluated for its effectiveness in a multi-center retrospective real-world study. Methods We included new-users of oral semaglutide from 18 specialist care centres and collected retrospective data on baseline clinical characteristics. Updated values of HbA1c and body
-
Novel variants ensued genomic imprinting in familial central precocious puberty J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-02-17
Abstract Introduction Central precocious puberty (CPP) is characterized by the early onset of puberty and is associated with the critical processes involved in the pubertal switch. The puberty-related gene pool in the human genome is considerably large though few have been described in CPP. Within those genes, the genomic imprinting features of the MKRN3 and DLK1 genes add additional complexity to
-
Should there be a paradigm shift for the evaluation of isthmic thyroid nodules? J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-02-16 Yağmur Babayid, Asena Gökçay Canpolat, Atilla Halil Elhan, Koray Ceyhan, Demet Çorapçıoğlu, Mustafa Şahin
-
Long-term prognostic value of thyroid hormones in left ventricular noncompaction J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-02-15 L. Liu, S. Cai, A. Chen, Y. Dong, L. Zhou, L. Li, Z. Zhang, Z. Hu, Z. Zhang, Y. Xiong, Z. Hu, Y. Li, M. Lu, L. Wu, L. Zheng, L. Ding, X. Fan, Y. Yao
-
Serum levels of adiponectin differentiate generalized lipodystrophies from anorexia nervosa J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-02-15 G. Ceccarini, C. Pelosini, M. Paoli, N. Tyutyusheva, S. Magno, D. Gilio, L. Palladino, M. R. Sessa, S. Bertelloni, F. Santini
-
The impact of telehealth education on self-management in patients with coexisting type 2 diabetes mellitus and hypertension: a 26-week randomized controlled trial J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-02-14 Hongjiang Ye, Ling Lin, Dongmei Zhong, Pin Chen, Xiaoqiong He, Zhurong Luo, Ping Chen
-
Successful localisation of recurrent thyroid cancer using preoperative patent blue dye injection J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-02-14
Abstract Purpose In the follow-up of patients with thyroid cancer, recurrences are often detected, posing challenges in locating and removing these lesions in a reoperative setting. This study aimed to assess the effectiveness of preoperative ultrasound (US)-guided injection of patent blue (PB) dye into the recurrences to aid in their safe and efficient removal. Methods In this retrospective analysis
-
Postmenopausal onset of androgen excess: a diagnostic and therapeutic algorithm based on extensive clinical experience J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-02-13 M. Luque-Ramírez, L. Nattero-Chávez, C. Rodríguez-Rubio Corona, A. E. Ortiz-Flores, A. M. García-Cano, M. Rosillo Coronado, B. Pérez Mies, I. Ruz Caracuel, H. F. Escobar-Morreale
-
The effects of ghrelin and LEAP-2 in energy homeostasis are modulated by thermoneutrality, high-fat diet and aging J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-02-09 S. Casado, M. Varela-Miguéns, T. de Oliveira Diz, C. Quintela-Vilariño, R. Nogueiras, C. Diéguez, S. Tovar
-
Role of IL33 in chronic inflammation and microvascular damage as a reflection of organ damage on a cohort of patients with acromegaly J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-02-08 D. Costa, C. Pellicano, V. Mercuri, E. D’Ascanio, G. Buglione, G. Cicolani, U. Basile, G. Leodori, P. Gargiulo, E. Rosato
-
When to suspect infantile hypercalcemia-1? J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-02-08
Abstract Purpose The screening test to suspect infantile hypercalcemia-1 (HCINF1) is the measure of 25(OH)D3/24,25(OH)2D3 ratio at mass spectroscopy (MS). When the ratio is > 80, the gold standard for the diagnosis is genetic analysis. Given its limited availability, MS may not represent a screening test and most cases of HCINF1 remain undiagnosed. Aim of the study is to identify cut-offs of serum
-
Glucocorticoid-induced adrenal insufficiency after therapy with intravenous methylprednisolone in patients with moderate-to-severe and active Graves’ orbitopathy: assessment with a low-dose corticotropin test J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-02-04 K. Pelewicz, P. Miśkiewicz
-
Different tumor growth pattern of clinically nonfunctioning pituitary neuroendocrine tumor according to sex and age: a longitudinal study J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-02-04 S. S. Park, H. Kang, Y. H. Kim, J. H. Kim
-
Endocrine manifestations in adults with 22q11.2 deletion syndrome: a retrospective single-center cohort study J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-02-03
Abstract Introduction and objective Patients with the 22q11.2 deletion syndrome (22q11DS) frequently display cardiological and psychiatric diseases, but are also at increased risk for endocrine manifestations. The aim of this study was to evaluate the screening, prevalence, and management of hypoparathyroidism and thyroid disease in patients with 22q11DS, to evaluate the metabolic profile, and to compare
-
Epicardial and pericoronary adipose tissue and coronary plaque burden in patients with Cushing’s syndrome: a propensity score-matched study J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-02-02 M. Wang, L. Qin, W. Bao, Z. Xu, L. Han, F. Yan, W. Yang
-
Persistent vaginal bleeding during gender-affirming hormone therapy in transgender men J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-02-01 E. D. da Silva, P. M. Spritzer, T. M. Fighera
-
A novel likely pathogenetic variant p.(Cys235Arg) of the MEN1 gene in multiple endocrine neoplasia type 1 with multifocal glucagonomas J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-01-31 C. Smirne, G. M. Giacomini, A. M. Berton, B. Pasini, F. Mercalli, F. Prodam, M. Caputo, L. A. A. Brosens, E. L. M. Mollero, R. Pitino, M. Pirisi, G. Aimaretti, E. Ghigo
-
Clinical and molecular characteristics of two Italian kindreds with hypoparathyroidism, deafness and renal dysplasia (HDR) syndrome J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-02-01 E. Dinoi, L. Pierotti, L. Mazoni, F. Citro, S. Della Valentina, C. Sardella, S. Borsari, A. Michelucci, M. A. Caligo, C. Marcocci, F. Cetani
-
Association of serum lipids and abnormal lipid score with cancer risk: a population-based prospective study J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-02-01 Y. Xie, Y. Jiang, Y. Wu, X. Su, D. Zhu, P. Gao, H. Yuan, Y. Xiang, J. Wang, Q. Zhao, K. Xu, T. Zhang, Q. Man, X. Chen, G. Zhao, Y. Jiang, C. Suo
-
Notch signaling regulates Th17 cells differentiation through PI3K/AKT/mTORC1 pathway and involves in the thyroid injury of autoimmune thyroiditis J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-01-29 C. He, Y. Li, L. Gan, Y. Lin, B. Zhang, L. Ma, H. Xue
-
Correlates of metabolic syndrome in people with chronic spinal cord injury J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-01-29
Abstract Purpose We aimed at identifying clinical risk factors or early markers of metabolic syndrome (MetS) in people with spinal cord injury (SCI) that would facilitate a timely diagnosis and implementation of preventive/therapeutic strategies. Methods One hundred sixty-eight individuals with chronic (> 1 year) SCI underwent clinical and biochemical evaluations. MetS was diagnosed according to modified
-
Ultrasound-based quantitative tools in predicting renal involvement in asymptomatic primary hyperparathyroidism J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-01-27 B. Candemir, F. Cuce, S. Akın, N. E. Gulcelik
-
Are sonographic characteristics of Hashimoto’s thyroiditis related with immunologic parameters? A cross-sectional study J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-01-21 K. Kenarlı, A. B. Bahçecioğlu, Ö. B. Aksu, S. Güllü
-
Real-life data of Pasireotide LAR in acromegaly: a long-term follow-up J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-01-20 C. Urbani, F. Dassie, B. Zampetti, R. Mioni, P. Maffei, R. Cozzi, F. Bogazzi
-
Gamma knife radiosurgery is effective in patients with thyrotropin-secreting pituitary adenomas J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-01-20 M. Losa, L. Albano, L. R. Barzaghi, M. Bailo, P. Mortini
-
A Delphi panel to build consensus on assessing disease severity and disease progression in adult patients with hypophosphatasia in the United States J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-01-18 K. M. Dahir, E. T. Rush, S. Diaz-Mendoza, P. S. Kishnani
-
Ketogenic nutritional therapy (KeNuT)—a multi-step dietary model with meal replacements for the management of obesity and its related metabolic disorders: a consensus statement from the working group of the Club of the Italian Society of Endocrinology (SIE)—diet therapies in endocrinology and metabolism J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-01-18 L. Barrea, M. Caprio, E. Camajani, L. Verde, S. Perrini, A. Cignarelli, F. Prodam, A. Gambineri, A. M. Isidori, A. Colao, F. Giorgino, G. Aimaretti, G. Muscogiuri
-
Gestational diabetes mellitus in patients undergoing assisted reproductive techniques or conceiving spontaneously: an analysis on maternal and foetal outcomes J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-01-16 S. Burlina, M. G. Dalfrà, A. Marchetto, A. Lapolla
Purpose With the rise of medically assisted reproductive techniques (ART) the number of pregnancies complicated by gestational diabetes mellitus (GDM) has increased. The aim of this study was to evaluate retrospectively the outcomes of pregnancies complicated by GDM who conceive trough ART (cases) compared to those who conceived spontaneously (controls). Methods In 670 women with GDM, 229 cases and
-
Semen quality and metabolic profile in people with type 1 diabetes with and without erectile dysfunction: a cross-sectional study J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-01-16 M. Longo, P. Caruso, C. Varro, M. Tomasuolo, P. Cirillo, L. Scappaticcio, L. Romano, D. Arcaniolo, M. I. Maiorino, G. Bellastella, M. De Sio, K. Esposito
-
The laywoman church builder Lucrezia Agliarti Vertova (ca 1484–March 24th 1557) had endemic goitre J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-01-13 R. Bianucci, A. Perciaccante, A. G. Nerlich
-
Association between type 2 diabetes and depressive symptoms after a 1-year follow-up in an older adult Mediterranean population J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-01-13 I. Baenas, L. Camacho-Barcia, R. Granero, C. Razquin, D. Corella, C. Gómez-Martínez, O. Castañer-Niño, J. A. Martínez, Á. M. Alonso-Gómez, J. Wärnberg, J. Vioque, D. Romaguera, J. López-Miranda, R. Estruch, F. J. Tinahones, J. Lapetra, J. L. Serra-Majem, N. Cano-Ibáñez, J. A. Tur, V. Martín-Sánchez, X. Pintó, J. J. Gaforio, P. Matía-Martín, J. Vidal, C. Vázquez, L. Daimiel, E. Ros, S. Jiménez-Murcia
-
Disease control of acromegaly does not prevent excess mortality in the long term: results of a nationwide survey in Italy J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-01-12 M. Arosio, V. Sciannameo, A. Contarino, P. Berchialla, S. Puglisi, A. C. Pesatori, E. Ferrante, M. Filopanti, R. Pivonello, F. Dassie, V. Rochira, S. Cannavò, E. De Menis, F. Pigliaru, S. Grottoli, V. Cambria, M. Faustini-Fustini, M. Montini, A. Peri, F. Ceccato, E. Puxeddu, G. Borretta, M. Bondanelli, D. Ferone, A. Colao, M. Terzolo, G. Reimondo
Objective This study aimed to assess the long-term outcome of patients with acromegaly. Design This is a multicenter, retrospective, observational study which extends the mean observation period of a previously reported cohort of Italian patients with acromegaly to 15 years of follow-up. Methods Only patients from the centers that provided information on the life status of at least 95% of their original